BERLIMATOXUMAB
UNII ES4FG3OV8Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Berlimatoxumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ES4FG3OV8Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1939109-24-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ES4FG3OV8Z
CAS Registry Number
1939109-24-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BERLIMATOXUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C169807
National Cancer Institute reference terminology for clinical and research data.
INN ID
10639
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Berlimatoxumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BERLIMATOXUMAB

Common Names & Synonyms

ASN-100 COMPONENT ASN-2
BERLIMATOXUMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS AUREUS LEUKOCIDIN LUKGH) (HUMAN MONOCLONAL ASN-2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ASN-2 LIGHT-CHAIN, DIMER

Technical Codes

ASN-2

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus